Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Search by ticker code:
Generic filters

Why The Bubs (ASX:BUB) Share Price Could Go Nuts Today

The Bubs Australia Ltd (ASX: BUB) share price will be on watch after it revealed its growth in the fourth quarter to June 2019.

Bubs was founded in 2006 by Kristy Carr and was listed on the ASX in January 2017. Its infant formula is based on goat milk and it also sells organic baby food. Bubs recently acquired NuLac Foods, Australia’s largest producer of goat milk products, it also guarantees exclusive supply of local goat milk from Australia’s largest herd of milking goats.

Bubs’ June 2019 Quarter Growth

Bubs reported that in the final quarter of FY19 it achieved 108% sales growth to $18.46 million compared to the last quarter of FY18. But, growth was 56% compared to just the previous quarter.

Impressively, Bubs’ fourth quarter revenue was higher than FY18’s entire revenue. The whole of FY19’s revenue amounted to $51.3 million, which represents an increase of 179%.

Perhaps even more importantly, the company achieved positive operating cashflow in the fourth quarter and it ended with $23.3 million of cash at 30 June 2019.

Looking at the categories, infant formula grew by 341% compared to the prior corresponding period and total Bubs products increased by 236%, representing 47% of gross sales in the quarter. Adult Dairy products grew 47% and represented 50% of gross sales. Deloraine production represented 2% of gross sales after the acquisition in April 2019.

Bubs had a very busy quarter after establishing a joint venture with Beingmate in China, a strategic equity-linked alliance with Chemist Warehouse, a major investment by C2 Capital Partners (of which Alibaba is a substantial investor), the acquisition of Deloraine (a CNCA licensed infant formula processing facility), a strategic eCommerce partnership with Alibaba’s Tmall, a partnership with Kidswant (China’s largest mother and baby store chain) and developing a organic grass-fed cow milk infant formula with Fonterra Shareholders’ Fund (ASX: FSF).

Bubs Founder and CEO Kristy Carr said: “This demonstrates the validity of our continuing focus on our four-pillar growth strategy, combined with underlying investments in supply chain and capabilities.”

Is Bubs A Buy?

Bubs seem to be delivering on its potential growth with a very strong end to FY19. The question is, can Bubs keep going at a strong pace for years like A2 Milk Company Ltd (ASX: A2M) has? I’m not sure. But in this era of lower interest rates, I’d be willing to think about it being a relatively small slice of my portfolio.

Bubs and the growth shares in the free report below could be worth watching.

[ls_content_block id=”14947″ para=”paragraphs”]

[ls_content_block id=”18380″ para=”paragraphs”]

$50,000 per year in passive income from shares? Yes, please!

With interest rates UP, now could be one of the best times to start earning passive income from a portfolio. Imagine earning 4%, 5% — or more — in dividend passive income from the best shares, LICs, or ETFs… it’s like magic.

So how do the best investors do it?

Chief Investment Officer Owen Rask has just released his brand new passive income report. Owen has outlined 10 of his favourite ETFs and shares to watch, his rules for passive income investing, why he would buy ETFs before LICs and more.

You can INSTANTLY access Owen’s report for FREE by CLICKING HERE NOW and creating a 100% FREE Rask Account.

(Psst. By creating a free Rask account, you’ll also get access to 15+ online courses, 1,000+ podcasts, invites to events, a weekly value investing newsletter and more!)

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.

Information warning: The information on this website is published by The Rask Group Pty Ltd (ABN: 36 622 810 995) is limited to factual information or (at most) general financial advice only. That means, the information and advice does not take into account your objectives, financial situation or needs. It is not specific to you, your needs, goals or objectives. Because of that, you should consider if the advice is appropriate to you and your needs, before acting on the information. If you don’t know what your needs are, you should consult a trusted and licensed financial adviser who can provide you with personal financial product advice. In addition, you should obtain and read the product disclosure statement (PDS) before making a decision to acquire a financial product. Please read our Terms and Conditions and Financial Services Guide before using this website. The Rask Group Pty Ltd is a Corporate Authorised Representative (#1280930) of AFSL #383169.

Skip to content